Data month 2026-08
Congruence Therapeuticscongruencetx.comAI-driven small-molecule drug-discovery company.
According to AlphaMoat, in 2026-08 Congruence Therapeutics (congruencetx.com) received 111 monthly visits (-96.3% MoM) — ranked #17,281 of 17,407 AI websites with traffic data, and #3,141 of 3,173 in Industry Services; its largest market is United States (100.0% of visits).
Monthly Visits · 2026-08
111-96.3%
Overall Rank (17,407)
#17,281
Industry Services Rank (3,173)
#3,141
Top Market
United States100.0%
What is Congruence Therapeutics
Product Overview
Congruence Therapeutics is a clinical-stage biotechnology company that uses AI-enabled protein-structure information, biology, and chemistry to discover small-molecule correctors and allosteric modulators targeting disease-causing proteins.
Key Features3 items
- 01Revenir engine starting from genetically validated hard targets
- 02Oral small-molecule pipeline across metabolic, neuro, immune and oncology
- 03Corrects disease at the molecular source
12-Month Traffic Trend
Hover for monthly values
Latest 111MoM-96.3%
2026-06
2.8K
—
2026-07
3.0K
+8.3%
2026-08
111
-96.3%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
111100.0%
Popular in Industry Services
Click for details, or "+ Compare" to compare with Congruence Therapeutics
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.